W.H. Sutherland

970 total citations
41 papers, 719 citations indexed

About

W.H. Sutherland is a scholar working on Radiation, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, W.H. Sutherland has authored 41 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiation, 11 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Molecular Biology. Recurrent topics in W.H. Sutherland's work include Advanced Radiotherapy Techniques (12 papers), Medical Imaging Techniques and Applications (4 papers) and Glycosylation and Glycoproteins Research (3 papers). W.H. Sutherland is often cited by papers focused on Advanced Radiotherapy Techniques (12 papers), Medical Imaging Techniques and Applications (4 papers) and Glycosylation and Glycoproteins Research (3 papers). W.H. Sutherland collaborates with scholars based in United Kingdom, Canada and France. W.H. Sutherland's co-authors include J A Pritchard, C. A. Joslin, John L. Moore, Robert M. Califf, Nancy E. Clapp‐Channing, Daniel B. Mark, Charlotte Nelson, J. David Knight, Paul W. Armstrong and C. David Naylor and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

W.H. Sutherland

36 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W.H. Sutherland United Kingdom 13 174 139 116 102 96 41 719
Gerald L. Logue United States 22 84 0.5× 76 0.5× 124 1.1× 127 1.2× 361 3.8× 53 1.1k
Shane Killeen Ireland 16 104 0.6× 100 0.7× 244 2.1× 84 0.8× 110 1.1× 40 868
Thomas V. Holohan United States 11 68 0.4× 51 0.4× 22 0.2× 137 1.3× 66 0.7× 19 464
Joseph Muldoon United States 12 114 0.7× 31 0.2× 291 2.5× 137 1.3× 43 0.4× 15 860
Margaret Merrell United States 6 125 0.7× 75 0.5× 36 0.3× 26 0.3× 116 1.2× 10 724
Dimitrios Kirmizis Greece 16 67 0.4× 30 0.2× 107 0.9× 77 0.8× 85 0.9× 39 882
Mohammed Ashraf Egypt 18 73 0.4× 427 3.1× 66 0.6× 100 1.0× 33 0.3× 46 1.0k
Alex D. Michaels United States 15 194 1.1× 39 0.3× 185 1.6× 184 1.8× 100 1.0× 23 840
Giampaolo Ugolini Italy 21 220 1.3× 60 0.4× 427 3.7× 141 1.4× 36 0.4× 81 1.2k
Bruce C. Berger United States 13 460 2.6× 508 3.7× 24 0.2× 36 0.4× 19 0.2× 19 952

Countries citing papers authored by W.H. Sutherland

Since Specialization
Citations

This map shows the geographic impact of W.H. Sutherland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.H. Sutherland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.H. Sutherland more than expected).

Fields of papers citing papers by W.H. Sutherland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.H. Sutherland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.H. Sutherland. The network helps show where W.H. Sutherland may publish in the future.

Co-authorship network of co-authors of W.H. Sutherland

This figure shows the co-authorship network connecting the top 25 collaborators of W.H. Sutherland. A scholar is included among the top collaborators of W.H. Sutherland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.H. Sutherland. W.H. Sutherland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pierga, Jean‐Yves, P. Fumoleau, Y. Brewer, et al.. (2004). Efficacy and safety of single agent capecitabine in pretreated metastatic breast cancer patients from the French compassionate use program. Breast Cancer Research and Treatment. 88(2). 117–129. 27 indexed citations
2.
Alexandre, Jérôme, Pascal Bleuzen, Jacques Bonneterre, et al.. (2000). Factors Predicting for Efficacy and Safety of Docetaxel in a Compassionate-Use Cohort of 825 Heavily Pretreated Advanced Breast Cancer Patients. Journal of Clinical Oncology. 18(3). 562–562. 70 indexed citations
3.
Mark, Daniel B., C. David Naylor, Mark A. Hlatky, et al.. (1994). Use of Medical Resources and Quality of Life after Acute Myocardial Infarction in Canada and the United States. New England Journal of Medicine. 331(17). 1130–1135. 257 indexed citations
4.
Sutherland, W.H., et al.. (1986). Demonstration of a high burnup heterogeneous core using ferritic/martensitic materials. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 4 indexed citations
5.
Sutherland, W.H.. (1984). Overview of core designs and requirements/criteria for core restraint systems. University of North Texas Digital Library (University of North Texas). 1 indexed citations
6.
Smith, C. W., et al.. (1982). A microcomputer system for prescription, calculation, verification and recording of radiotherapy treatments. British Journal of Radiology. 55(652). 283–288. 3 indexed citations
7.
Karmis, Michael, et al.. (1981). Proceedings of the fourteenth annual institute on coal mining health, safety and research. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 2 indexed citations
8.
Sutherland, W.H.. (1980). An approach to computerised treatment calculation and verification (CTCV) in radiotherapy, based on a study of mistakes in one centre.. PubMed. 46(547). 157–62. 2 indexed citations
9.
Pritchard, J A & W.H. Sutherland. (1978). Lymphocyte response to antigen stimulation as measured by fluorescence polarization (SCM test). British Journal of Cancer. 38(2). 339–343. 17 indexed citations
10.
Pritchard, J A, et al.. (1978). CANCER-SPECIFIC DENSITY CHANGES IN LYMPHOCYTES AFTER STIMULATION WITH PHYTOHÆMAGGLUTININ. The Lancet. 312(8103). 1275–1277. 18 indexed citations
11.
Pritchard, J A, John L. Moore, W.H. Sutherland, & C. A. Joslin. (1976). Clinical assessment of the MOD-MEM cancer test in controls with non-malignant diseases. British Journal of Cancer. 34(1). 1–6. 19 indexed citations
12.
Sutherland, W.H.. (1976). Stability of a linear accelerator with “achromatic” electron beam bending. British Journal of Radiology. 49(579). 262–266.
13.
Pritchard, J A, W.H. Sutherland, & T. J. Deeley. (1976). CANCER DETECTION. The Lancet. 307(7960). 637–637. 20 indexed citations
14.
Pritchard, J A, John L. Moore, W.H. Sutherland, & C. A. Joslin. (1974). Proceedings: Clinical and technical evaluation of the MOD-NEM test for malignant disease. British Journal of Cancer. 30(2). 185–186.
15.
Johns, E.W., J A Pritchard, John L. Moore, et al.. (1973). Histones and Cancer Test. Nature. 245(5420). 98–99. 10 indexed citations
16.
Pritchard, J A, John L. Moore, W.H. Sutherland, & C. A. Joslin. (1972). Immunodiagnosis of cancer.. BMJ. 3(5830). 823–823. 8 indexed citations
17.
Jackson, R.J., et al.. (1970). SWELLING AND CREEP EFFECTS UPON FAST REACTOR CORE STRUCTURAL DESIGN.. Transactions of the American Nuclear Society. 1 indexed citations
18.
Moore, John L., et al.. (1970). Some Unexpected Dosimetric Problems in an Apparatus for Mammalian Radiobiology. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine. 18(3). 287–289. 1 indexed citations
19.
Sutherland, W.H.. (1969). Dose monitoring methods in medical linear accelerators. British Journal of Radiology. 42(503). 864–864. 3 indexed citations
20.
Sutherland, W.H., et al.. (1956). Some aspects of hospital infection. The American Journal of Surgery. 92(2). 233–239. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026